Drug Profile
Fluorouracil irinotecan companion diagnostic - Everist Genomics
Alternative Names: OncoDefender-CRC; OncoSelectorLatest Information Update: 19 Mar 2012
Price :
$50
*
At a glance
- Originator Everist Genomics
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Colorectal cancer
Most Recent Events
- 14 Mar 2012 Launched for Colorectal cancer (diagnosis) in USA (unspecified route)